Connective tissue growth factor and tissue inhibitor of matrix metalloproteinase-2 in patients with exfoliative glaucoma

Current Eye Research

Volumn 36, Issue 6, 2011, Pages 540-545

  Ghanem, Asaad A ^a   Arafa, Lamiaa F ^a   El Baz, Ayman ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Aqueous humor; Cataract; CTGF; Glaucoma; MMP 2; TIMP 2

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; AQUEOUS HUMOR FLOW; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXFOLIATIVE GLAUCOMA; FEMALE; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; PARACENTESIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN CONTENT; SENILE CATARACT;

AGED; AQUEOUS HUMOR; BIOLOGICAL MARKERS; CATARACT; CONNECTIVE TISSUE GROWTH FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXFOLIATION SYNDROME; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 79956277752     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.565541     Document Type: Article

References (28)

1. Schlötzer-Schrehardt U, Lommatzsch J, Kuchle M, et al. Matrix metalloproteinases and their inhibitors in aqueous humor of patients with pseudoexfoliation syndrome/glaucoma and primary open-angle glaucoma. Invest Ophthalmol Vis Sci. 2003;44:1117-1125. (Pubitemid 36300758)
2. Brinckerhoff CE, Matrisian LM. Matrix metalloproteinases: A tail of a frog that becomes a prince. Nat Rev Mol Cell Biol. 2002;3:207-214.
3. Kossakowska AE, Edwards DR, Lee SS, et al. Altered balance between matrix metallproteinases and their inhibitors in experimental biliary fibrosis. Am J Pathol. 1998;153:1895-1902. (Pubitemid 28550676)
4. Sethi CS, Bailey TA, Luthert PJ, et al. Matrix metalloproteinases biology applied to vitreoretinal disorders. Br J Ophthalmol. 2000;84:654-666. (Pubitemid 30339323)
5. Tamiya S, Wormstone IM, Marcantonio JM, et al. Induction of matrix metalloproteinases 2and 9 following stress to the lens. Exp Eye Res. 2000;71:591-597. (Pubitemid 32002245)
6. Dushku N, John MK, Schultz GS, et al. Pterygia pathogenesis: Corneal invasion by matrix metalloproteinases expressing altered limbal epithelial basal cells. Arch Ophthalmol. 2001;119:695-706. (Pubitemid 32417376)
7. Pang IH, Helberg PE, Fleenor DL, et al. Expression of matrix metalloproteinases and their inhibitors in human trabecular meshwork cells. Invest Ophthalmol Vis Sci. 2003;44:3485-4393.
8. Abreu JG, Ketpura NI, Reversade B, et al. Connective tissue growth factor modulates cell signalling by BMB and TGFbeta. Nat Cell Biol. 2002;4:599-604.
9. Yang M, Huang H, Li J, et al. Connective tissue growth factor increases matrix metalloproteinase-2 and suppresses tissue inhibitor of matrix metalloproteinases-2 production by cultured renal interstitial fibroblasts. Wound Rep Reg. 2007;15:817-824. (Pubitemid 350135228)
10. Tripathi RC, Borisuth NSC, Li J, et al. Growth factors in the aqueous humor and their clinical significance. J Glaucoma. 1994;3:248-258. (Pubitemid 24267872)
11. Igrashi A, Okochi H, Bradhan DM, et al. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993;4:637-645. (Pubitemid 23183611)
12. Cellini M, Leonetti P, Strobbe E, et al. Matrix metalloproteinases and their inhibitors after selective laser trabeculoplasty in pseudoexfoliative secondary glaucoma. BMC Ophthalmol. 2008;8:20.
13. Yildirim N, Sahin A, Erol N, et al. The relationship between plasma MMP-9 and TIMP-2 levels and intraocular pressure elevation in diabetic patients after intravitreal triamcinolone injection. J Glaucoma. 2008;17:253-256.
14. Ball DK, Surveyor GA, Diehl JR, et al. Characterization of 16-20 Kilodalton connective tissue growth factors and demonstration of proteolytic activity for 38-KDa CTGF in pig uterine luminal (KDa) flushing. Biol Reprod. 1998;59:828-835. (Pubitemid 28463334)
15. Dong Z. Matrix metalloproteinases. Clin Exp Metastasis. 2001;17:555.
16. Davidson B. Matrix metalloproteinase inhibitors. Eur J Cancer. 2001;37:2040.
17. Lowry OH, Rosenbrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265-275.
18. Esson DW, Neelakantan A, Iyer SA, et al. Expression of connective tissue growth factor after glaucoma filtering surgery in rabbit model. Invest Ophthalmol Vis Sci. 2004;45:485-491. (Pubitemid 38140505)
19. Määttä M, Tervahartiala T, Airaksinen J, et al. Matrix metalloproteinases and their tissue inhibitors in aqueous humor of patients with primary open-angle glaucoma, exfoliation syndrome, and exfoliation glaucoma. J Glaucoma. 2005;14:64-69. (Pubitemid 40165495)
20. Rönkkö S, Rekonen P, Kaarnirantak K, et al. Matrix metalloproteinases and their inhibitors in the chamber angle of normal eyes and patients with primary open-angle glaucoma and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol. 2007;5:697-704. (Pubitemid 46951236)
21. Mulholland B, Tuft SJ, Khaw PT. Matrix metalloproteinase distribution during early corneal wound healing. Eye. 2005;19:584-588. (Pubitemid 40711716)
22. Schlötzer-Schrehardt U, Naumann GOH. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. Invest Ophthalmol Vis Sci. 1995;36:1750-1764.
23. Konstas AGP, Koliakos GG, Karabatsas CH, et al. Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma. Exp Eye Res. 2006;82:319-322. (Pubitemid 43122118)
24. Crean JKG, Lappin DWP, Godson C, et al. Connective tissue growth factor: An attractive therapeutic target in fibrotic renal disease. Expert Opin Ther Targets. 2001;5:519-530. (Pubitemid 33804247)
25. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF), and cystein-rich 61 (CyR61). Angiogenesis. 2002;5:153-165. (Pubitemid 36687518)
26. Blalock TD, Duncan MR, Varela JC, et al. Connective tissue growth factor expression and action in human corneal fibroblasts cultures and rat corneas after photorefractive keratectomy. Invest Ophthalmol Vis Sci. 2003;44:1879-1887. (Pubitemid 36520276)
27. Van Setten G, Aspiotis M, Blalock TD, et al. Connective tissue growth factor in pterygium: Simultaneous presence with vascular endothelial growth factor. Possible contributing factor to conjunctival scarring. Graefes Arch Clin Exp Ophthalmol. 2003;241:135-139. (Pubitemid 36747801)
28. Ho SL, Dogar GF, Wang J, et al. Elevated aqueous humor tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol. 2005;89:169-173. (Pubitemid 40175213)